Abstract
A series of some newer 2, 5-disubstituted-1, 3, 4-oxadiazole derivatives (5a-5j) were synthesized and evaluated for anticancer activity. Compound 5f showed excellent activity in majority of the cell lines.
Keywords: 2,5-Disubstituted-1,3,4-oxadiazole, Schiff's bases, 4-Thiazolidinone derivatives, Anticancer activity
Letters in Drug Design & Discovery
Title: Synthesis and Anticancer Evaluation of some Newer 2, 5-Disubstituted-1,3, 4-Oxadiazole Analogues
Volume: 5 Issue: 6
Author(s): Rakesh R. Somani, Prabhakar Y. Shirodkar and Vilasrao J. Kadam
Affiliation:
Keywords: 2,5-Disubstituted-1,3,4-oxadiazole, Schiff's bases, 4-Thiazolidinone derivatives, Anticancer activity
Abstract: A series of some newer 2, 5-disubstituted-1, 3, 4-oxadiazole derivatives (5a-5j) were synthesized and evaluated for anticancer activity. Compound 5f showed excellent activity in majority of the cell lines.
Export Options
About this article
Cite this article as:
Somani R. Rakesh, Shirodkar Y. Prabhakar and Kadam J. Vilasrao, Synthesis and Anticancer Evaluation of some Newer 2, 5-Disubstituted-1,3, 4-Oxadiazole Analogues, Letters in Drug Design & Discovery 2008; 5 (6) . https://dx.doi.org/10.2174/157018008785777360
DOI https://dx.doi.org/10.2174/157018008785777360 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
“Care-Getting”: A Conceptual Model of Marshalling Support Near the End of Life
Current Aging Science PEO-PPO Block Copolymers for Passive Micellar Targeting and Overcoming Multidrug Resistance in Cancer Therapy
Current Drug Targets A Systematic Evaluation of Solubility Enhancing Excipients to Enable the Generation of Permeability Data for Poorly Soluble Compounds in Caco-2 Model
Drug Metabolism Letters Multi-target Activities of Selected Alkaloids and Terpenoids
Mini-Reviews in Organic Chemistry The CXCR4/SDF-1 Chemokine Axis: A Potential Therapeutic Target for Bone Metastases?
Current Pharmaceutical Design MDR1/P-Glycoprotein (ABCB1) as Target for RNA Interference-Mediated Reversal of Multidrug Resistance
Current Drug Targets Nanotechology-Based Strategies to Enhance the Efficacy of Photodynamic Therapy for Cancers
Current Drug Metabolism Inflammatory Bowel Disease: New Therapeutic Options in the Post Anti-TNFα Era
Current Drug Metabolism Peroxisome Proliferator-Activated Receptors: Role of Isoform Gamma in the Antineoplastic Effect of Iodine in Mammary Cancer
Current Cancer Drug Targets Integrin-Mediated Drug Resistance
Current Signal Transduction Therapy Rheumatoid Arthritis: An Evolutionary Force in Biologics
Current Pharmaceutical Design Paclitaxel Efficacy is Increased by Parthenolide via Nuclear Factor- KappaB Pathways in In Vitro and In Vivo Human Non–Small Cell Lung Cancer Models
Current Cancer Drug Targets Therapeutic Applications of Mesenchymal Stem Cells: A Comprehensive Review
Current Stem Cell Research & Therapy Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines
Medicinal Chemistry Erratum
Current Proteomics Advances in Nanomaterials for Diagnosis and Therapy of Leukemia
Recent Patents on Nanomedicine Effects of Tea Polyphenols and their Polymers on MAPK Signaling Pathways in Cancer Research
Mini-Reviews in Medicinal Chemistry Facile Synthesis of Hollow Mesoporous Hydroxyapatite Nanoparticles for Intracellular Bio-imaging
Current Nanoscience Identification of tRNA-Derived Fragments Expression Profile in Breast Cancer Tissues
Current Genomics Arsenic Trioxide Exerts Anti-lung Cancer Activity by Inhibiting Angiogenesis
Current Cancer Drug Targets